Income tax expense · 2011–2025
Teva Pharmaceutical Industries income tax expense
−$180M−$856M · FY2025
Teva Pharmaceutical Industries (TEVA) reported −$180M in income tax expense for fiscal 2025, −$856M from the year before.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$180M | −$856M | Open → |
| FY20242024-12-31 | $676M | +$683M | Open → |
| FY20232023-12-31 | −$7.0M | +$636M | Open → |
| FY20222022-12-31 | −$643M | −$854M | Open → |
| FY20212021-12-31 | $211M | +$379M | Open → |
| FY20202020-12-31 | −$168M | +$110M | Open → |
| FY20192019-12-31 | −$278M | −$83.0M | Open → |
| FY20182018-12-31 | −$195M | +$1.7B | Open → |
| FY20172017-12-31 | −$1.9B | −$2.5B | Open → |
| FY20162016-12-31 | $521M | −17.8% | Open → |
| FY20152015-12-31 | $634M | +7.3% | Open → |
| FY20142014-12-31 | $591M | +$634M | Open → |
| FY20132013-12-31 | −$43.0M | +$94.0M | Open → |
| FY20122012-12-31 | −$137M | −$264M | Open → |
| FY20112011-12-31 | $127M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Teva Pharmaceutical Industries income tax expense |url=https://companiesranked.com/en/company/teva-pharmaceutical-industries/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Teva Pharmaceutical Industries income tax expense. CompaniesRanked. https://companiesranked.com/en/company/teva-pharmaceutical-industries/income-tax-expenseBibTeX
@misc{companiesranked-en-company-teva-pharmaceutical-industries-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Teva Pharmaceutical Industries income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/teva-pharmaceutical-industries/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-034532 · February 3, 2026
{{cite web |title=Teva Pharmaceutical Industries income tax expense — 10-K (0001193125-26-034532) |url=https://www.sec.gov/Archives/edgar/data/818686/000119312526034532/d93612d10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.